New hope for transplant patients battling dangerous virus
Disease control
Recruiting now
This study is testing whether adding an intravenous drug called artesunate to standard antiviral medications helps control cytomegalovirus (CMV) infection better in people who have received organ transplants. Researchers will compare the combination treatment against standard tre…
Phase: PHASE2 • Sponsor: Amivas Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC